N/A N=66 Comparison of the Effectiveness of USG and Palpation Guidance Steroid Injection in Patients With Plantar Fasciitis
Plantar Fasciitis
Primary: Pain Severity — 8.50; 8.31 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=408 Evaluation of Dupilumab in Children With Uncontrolled Asthma
Asthma
Primary: Annualized Rate of Severe Exacerbation Events During the 52-Week Treatment Period: Baseline Blood Eosinophils >=300 Cells Per Microliter Population — 0.665; 0.235…
N/A N=349 Optimizing Risk Messages for Waterpipe Tobacco Cessation in Young Adults
Hookah Smoking
Primary: Perceived Harm — 4.1; 4.2; 4.5 score on a scale
N/A N=82 Penile Length Maintenance Post-Prostatectomy
Prostate Cancer · Penile Diseases
Primary: Change in Penile Length — 0.3; 1.6 centimeters
Phase 2 N=366 Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Primary: Slope of Change From Baseline in the ALS Functional Rating Scale (ALSFRS-R) — -1.05; -1.00 Units on a Scale per Month — p=0.4807
Phase 1 N=98 Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults
Healthy Volunteer
Primary: Part 1: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 2; 0; 0; 1 Participants
N/A N=30 Goal Directed Therapy Versus Standard Care in Lung Resection Surgery (GDT-thorax Study).
Goal Directed Therapy · Fluid Therapy
Primary: Percentage of the Intraoperative Time in Which the Cardiac Index is Equal or Superior to 2.2 l/Min/m2 (%) — 97; 91 percentage of time — p=0.114
Phase 2 N=28 Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recurrent Fallopian Tube Carcinoma · Recurrent Ovarian Carcinoma · Recurrent Primary Peritoneal Carcinoma
Primary: Overall Objective Response Rate (ORR) Based on Response Evaluation Criteria in Solid Tumors and by Rustin's Criteria (RECIST) — 4; 5; 9; 4 Participants
N/A N=19 34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms
Abdominal Aortic Aneurysm
Primary: Number of Participants With Proximal Type I Endoleak at Each Timepoint — 1; 0; 0; 0 Participants
N/A N=102 Spineology Clinical Outcomes Trial: An IDE Investigation
Lumbar Degenerative Disc Disease
Primary: Overall Success — 71 Participants
N/A N=60 Project EQuIP: Empowering Queer Identities in Psychotherapy
Sexual Minority Stress
Primary: Depression — 27.57; 29.70; 26.86; 20.44 score on a scale
Phase 3 N=312 Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)
Anaemia
Primary: Mean Change From Baseline in Hemoglobin (Hgb) During Evaluation Period (Week 28 to Week 52) — 1.02; 1.12 Grams per deciliter
Phase 3 N=478 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) — -1.87; -1.89; -2.07; 0.04 Percentage of HbA1c — p=<0.001
Phase 2 N=15 Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia
Hypertriglyceridemia
Primary: HDL 15-HEPE — 3.7; 10.4 nmol/mmol phospholipid
N/A N=11,314 Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors
Cancer of Prostate · Cancer of the Prostate · Prostate Cancer
Primary: Overall Survival — 8.7; 8.8; 8.6; 9.0 years